Skip to main content
. 2023 Dec 8;7:e53293. doi: 10.2196/53293

Table 1.

Demographic and baseline characteristics.

Baseline variables Patients with repeat measures (n=1826), n (%) Patients with 1 measure (n=4639, n (%) P valuea
Sex .06

Female 1084 (59.36) 2620 (56.48)

Male 395 (21.63) 1086 (23.41)

Undisclosed 347 (19) 933 (20.11)
Age (y), mean (SD) 39.38 (13.53) 33.32 (10.05) <.001
Insurance type <.001

Commercial insurance 1618 (88.61) 4409 (95.04)

Medicare 138 (7.56) 84 (1.81)

Self-pay 70 (3.83) 146 (3.15)
Baseline GAD-7b .90

Minimal anxiety 224 (12.27) 544 (11.73)

Mild anxiety 528 (28.92) 1332 (28.71)

Moderate anxiety 541 (29.63) 1376 (29.66)

Severe anxiety 533 (29.19) 1387 (29.9)
Baseline PHQ-8c .49

Minimal depression 254 (13.91) 567 (12.22)

Mild depression 475 (26.01) 1260 (27.16)

Moderate depression 530 (29.03) 1383 (29.81)

Moderately severe depression 394 (31.58) 1032 (22.25)

Severe depression 173 (9.47) 397 (8.56)
Geographic classification .01

Urban 1710 (93.65) 4420 (95.28)

Rural 116 (6.35) 218 (4.7)

Number of days between visits 102.63 (34.15) N/Ad

aP values obtained from chi-square tests comparing the group that completed repeated measurements and the group that completed 1 measurement.

bGAD-7: Generalized Anxiety Disorder–7.

cPHQ-8: Patient Health Questionnaire–8.

dN/A: not available as second measurement not completed.